A Pitta-predominant person with mildly raised liver enzymes, right-sided heaviness after meals, sluggish bowels, and early fatty-liver changes needs a plan that protects the liver while restoring regular elimination. In Ayurveda, full virechana is the classical purgative therapy used for Pitta-predominant disorders, but not every patient needs or tolerates formal Panchakarma purgation. For carefully selected patients, a qualified practitioner may choose a gentler anulomana or bhedana approach that moves the bowels without the intensity of full virechana.

The rhubarb-root drug for this purpose is best identified as Revand Chini, Himalayan rhubarb, Rheum australe D.Don, with Rheum emodi Wall. ex Meisn. treated botanically as a synonym. This correction matters because the Ayurvedic Pharmacopoeia of India identifies Amlavetasa Phala as a different drug: the fruit rind of Garcinia pedunculata. Both drugs can appear in digestive contexts, but rhubarb root should not be substituted for the official Amlavetasa Phala of classical formulations.

Identity: Amlavetasa Phala and Revand Chini Are Not the Same Drug

According to the Ayurvedic Pharmacopoeia of India, Amlavetasa Phala, also listed under Vṛntāmlaphala, consists of the fruit rind of Garcinia pedunculata Roxb. Its Ayurvedic profile is amla and kashaya rasa, ruksha, tikshna, snigdha, and laghu guna, ushna virya, and amla vipaka. Its actions are listed as anulomaka, bhedana, dipana, kaphahara, mutrala, pachana, and vatahara, with fresh juice dose given as 5–10 ml.

Revand Chini, by contrast, refers to Himalayan rhubarb root or rhizome. The accepted botanical name is Rheum australe D.Don, and Rheum emodi is treated as a synonym. This plant grows across the Himalayan region and is used in traditional digestive and bowel-moving contexts. When an Ayurvedic liver-cleansing discussion is actually about rhubarb root, the accurate name is Revand Chini or Himalayan rhubarb, not Amlavetasa Phala.

Why Revand Chini Sits at the Gentle End of Purgation

Rhubarb root contains hydroxyanthracene derivatives such as rhein, emodin, aloe-emodin, chrysophanol, physcion, and their glycosides, along with tannin compounds such as gallotannins. The anthranoid fraction acts mainly through the colon and supports bowel evacuation after metabolic activation, while the tannin fraction gives rhubarb a more complex profile than a simple stimulant laxative.

This combination explains why rhubarb root is often treated as a milder bowel-moving herb than stronger purgative agents. Its laxative action generally appears after 8–12 hours, making evening administration the usual timing in standardized herbal monographs. In Ayurvedic language, this places Revand Chini closer to short-course anulomana and mild bhedana than to aggressive purgation.

How This Fits Liver-Pitta Support

In a liver-pitta presentation, the aim is not simply to force purgation. The aim is to reduce excess heat, heaviness, sluggish digestion, and bowel stagnation while protecting strength. A practitioner may consider Revand Chini when the clinical picture includes Pitta signs with constipation or incomplete evacuation, especially where metabolic liver strain is being managed alongside diet, weight reduction, exercise, sleep correction, and medical monitoring.

For fatty-liver patterns, the foundation remains lifestyle and medical care: reducing excess body weight when present, increasing physical activity, improving diet quality, avoiding alcohol when it contributes to liver injury, and monitoring liver enzymes and metabolic markers. Revand Chini should be viewed as a short-course bowel-regulating support within that wider plan, not as a stand-alone cure for fatty liver or a replacement for hepatology care.

Practitioner-Guided Administration

Rhubarb root should be dosed by its hydroxyanthracene derivative content, not by casual spoon measurements of raw powder. European herbal monographs describe adult and adolescent use above 12 years of age as a single evening dose equivalent to 20–30 mg hydroxyanthracene derivatives, calculated as rhein. The correct individual dose is the smallest amount needed to produce a comfortable, soft-formed stool.

For an Ayurvedic liver-pitta plan, this means Revand Chini belongs in supervised, short-duration use. It is not a daily liver tonic, and it is not appropriate for repeated self-cleansing. Food, sleep, bowel habits, menstrual status, hydration, current medicines, kidney history, and liver investigations should all be reviewed before use.

Comparison with Other Virechana and Anulomana Options

Best-Fit Clinical Pattern

Revand Chini is best suited to a narrow clinical pattern: Pitta-type heaviness, bitter or sour digestive discomfort, sluggish bowels, heat signs, and the need for gentle downward movement. In liver-pitta care, it may be considered when the bowels are clearly part of the picture and the patient is strong enough for a short bowel-moving intervention.

It is less appropriate when the person is depleted, dehydrated, underweight, actively inflamed in the gut, pregnant, breastfeeding, or already passing loose stools. It is also not the first answer for unexplained liver enzyme elevation, jaundice, suspected bile-duct obstruction, viral hepatitis, drug-induced liver injury, advanced liver disease, or severe abdominal pain. Those require medical diagnosis and monitoring before any cleansing protocol is considered.

When to Avoid Rhubarb Root

Rhubarb-root laxative preparations should be avoided in pregnancy, breastfeeding, and children under 12 years of age. They should also be avoided in intestinal obstruction or stenosis, intestinal atony, appendicitis, inflammatory bowel disease such as Crohn’s disease or ulcerative colitis, unexplained abdominal pain, and severe dehydration with water or electrolyte depletion.

Long-term or repeated use is not appropriate. Overuse can cause abdominal cramping, diarrhea, fluid loss, electrolyte disturbance, and potassium depletion. Caution is also required in people taking cardiac glycosides, antiarrhythmic medicines, medicines that prolong the QT interval, diuretics, corticosteroids, or liquorice root, because electrolyte changes can increase risk.

Medical Disclaimer: This post is for educational purposes only and does not constitute medical advice. Liver conditions require diagnosis and monitoring by a qualified physician. Rhubarb-root preparations should not be used as a self-prescribed liver cleanse. Consult a qualified Ayurvedic practitioner and healthcare provider before using any purgative herb, especially if liver enzymes are elevated, medicines are being taken, or pregnancy, breastfeeding, bowel disease, kidney disease, or dehydration is present.

References

1. Clinical study to evaluate the effect of Virechanakarma on serum electrolytes (2013), PubMed Central
2. Powo (powo.science.kew.org)
3. Powo (powo.science.kew.org)
4. Dravyaguna notes
5. Sciencedirect (sciencedirect.com)
6. Ema (ema.europa.eu)
7. Ema (ema.europa.eu)
8. Ema (ema.europa.eu)
9. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease (2023), PubMed Central
10. Aasld (aasld.org)
11. Ayurvedic Pharmacopoeia of India
12. Ayurvedic Pharmacopoeia of India

The strength of Danti is exactly why it deserves attention. Used correctly, it has an honoured place in Virechana Karma and in formulations for conditions involving obstruction, heaviness, abdominal disorders, skin disease, swelling, worms, piles, spleen-related disorders, and jaundice described in Ayurvedic terminology. Used casually, it can cause painful purgation, nausea, diarrhoea, dehydration, and serious harm.

Botanical Identity and Names

Danti is the Ayurvedic drug prepared from the dried root of Baliospermum montanum (Willd.) Müll.Arg., family Euphorbiaceae. Some current botanical references also cross-reference this plant with Baliospermum solanifolium (Burm.) Suresh, while Ayurvedic pharmacopoeial and classical sources commonly retain the name Baliospermum montanum for Danti.

• Sanskrit: Danti; classical synonyms include Udumbaraparni, Nikumbha, and Mukulaka
• English: Wild Croton
• Hindi, Bengali, Gujarati, Marathi, Odia, Punjabi, Tamil, Urdu: Danti
• Kannada: Kadu Haralu
• Malayalam: Neervalam, Dantti; regional Kerala sources also record Dantika and Nagadanthi
• Telugu: Konda Amudamu

The official Ayurvedic Pharmacopoeia of India monograph describes Danti as a leafy undershrub distributed in the outer Himalayan range from Kashmir to Assam and in moist deciduous forests elsewhere in India. The official drug part is the dried root.

Why Danti Is a Potent Purgative Herb

In Ayurveda, Danti belongs to the class of sharp medicines used for downward elimination. Charaka Samhita devotes a Kalpa Sthana chapter to pharmaceutical preparations of Danti and Dravanti for therapeutic purgation, and the chapter describes multiple Danti-Dravanti formulations intended for controlled Virechana.

Danti is selected when the physician needs a stronger eliminative action than mild bowel-regulating herbs can provide. Its sharp, hot, quick-acting nature makes it useful in Kapha-heavy and obstructive patterns, but the same properties make it unsuitable for casual self-administration.

Classical Ayurvedic Profile of Danti

The Ayurvedic Pharmacopoeia of India gives the official pharmacopoeial profile of Danti root as follows. This profile corrects the common mistake of describing Danti as a gentle Vata-reducing laxative; classical descriptions treat it as sharp, hot, and powerful.

In practical terms, Danti is hot, sharp, penetrating, and moving. It kindles digestion, breaks stagnation, and pushes elimination downward. This is why it is valued in Virechana, and also why it can disturb a weak, dry, depleted, pregnant, elderly, or inflamed body if used without proper assessment.

Danti in Virechana Karma

Virechana is therapeutic purgation and is one of the principal Panchakarma procedures. It is classically used for Pitta-dominant and Pitta-associated disorders, especially when morbid doṣas need to be expelled through the lower gastrointestinal route.

Danti may be used as a purgative ingredient in carefully designed Virechana preparations. Charaka’s Dantidravanti Kalpa describes collection, processing, and multiple media for administering Danti and Dravanti preparations, including combinations used in conditions such as gulma and udara described in Ayurvedic terminology.

A formal Virechana course is not the same as taking a laxative. The physician assesses prakriti, vikriti, strength, age, digestion, bowel tendency, disease state, season, and tolerance. Classical Virechana is commonly preceded by preparatory measures such as snehana and swedana, followed by a graduated post-purgation diet. Shorter or emergency forms are physician-decided exceptions, not a basis for home experimentation.

Shodhana and Classical Processing

Charaka Samhita describes a processing method for Danti and Dravanti roots in which the roots are smeared with Pippali and honey, wrapped with Kusha, coated with mud, heated, and then dried in sunlight. This processing is described as reducing the vikasi effect of the drugs, helping regulate their strong action.

This point matters because Danti is not merely “powdered root.” The selection of mature root, correct processing, and appropriate vehicle are part of its safe Ayurvedic use. A raw, uncertain, adulterated, or incorrectly processed material can behave unpredictably.

Which Part of Danti Is Officially Used?

The official single-drug monograph in the Ayurvedic Pharmacopoeia of India is for Danti root. Classical and later Ayurvedic literature also records external and compound uses of Danti in many dosage forms, but the safest public guidance is to treat the root as the official pharmacopoeial drug and to leave seed, seed oil, strong compound, and mineral-herbal preparations to trained physicians.

Traditional Uses Beyond Purgation

Danti is best known for Virechana, but the Ayurvedic Pharmacopoeia of India also lists a wider therapeutic range. These uses should be understood as classical Ayurvedic indications, not as permission to self-treat serious medical conditions.

Skin Disorders and Itching

The API monograph includes tvakadosha, kandu, and kushtha among Danti’s therapeutic uses. In Ayurvedic reasoning, strong purification may be selected when skin disease is linked with deep Kapha-Pitta obstruction, impaired digestion, and vitiated blood-related pathology.

Swelling, Ascites, and Abdominal Disorders

Danti is listed for shotha and udararoga, and Charaka’s Danti-Dravanti formulations include contexts such as gulma and udara. These are serious clinical categories; Danti belongs in supervised care, especially where abdominal swelling, fluid accumulation, or organ-related disease is suspected.

Worms, Piles, and Obstructive Digestive States

The API lists krimi, arsha, gulma, and shularoga among Danti’s uses. Its value here lies in its sharp, cleansing, moving action, but excessive purgation can worsen weakness, bleeding, dehydration, or painful ano-rectal conditions.

Spleen-Related and Jaundice-Related Conditions

The API includes pliha and kamala among therapeutic uses. These categories require proper diagnosis and medical supervision. Danti should never be used as a home “liver cleanse” for jaundice, hepatitis, gallbladder disease, or unexplained abdominal symptoms.

Phytochemical Note

The Ayurvedic Pharmacopoeia of India lists beta-sitosterol, triterpenoids, resinous glycosides, and phorbol esters among Danti root constituents. The presence of resinous glycosides and phorbol ester-type constituents fits the traditional understanding of Danti as a sharp purgative rather than a mild nutritive herb.

This is also why quality matters. The drug should be correctly identified, properly processed, free from adulteration, and used only in an appropriate dose and vehicle. More is not better with Danti.

Dosage Guidelines

The official adult dose in the Ayurvedic Pharmacopoeia of India is 1–3 g of Danti root in powder form. This is a pharmacopoeial guidance range for clinicians, not a recommendation for self-use. In practice, the dose is adjusted according to bowel tendency, strength, age, preparation, disease state, and whether the drug is being used as part of a formal Virechana protocol.

Contraindications and Safety

Danti should be treated as a potent clinical purgative. It is not suitable for casual constipation relief, weight loss, internet-led detoxing, or unsupervised Panchakarma at home.

• Avoid during pregnancy and lactation unless a qualified physician gives condition-specific guidance; pregnancy is a strong practical contraindication for purgative use.
• Avoid in children unless prescribed by a specialist.
• Avoid in frail, elderly, severely underweight, dehydrated, or debilitated people unless carefully supervised.
• Avoid during active diarrhoea, dysentery, severe dehydration, acute abdominal pain, intestinal obstruction, or acute inflammatory bowel flare.
• Use extreme caution in bleeding piles, severe fissure pain, recent surgery, kidney disease, electrolyte disturbance, or when taking medicines affected by diarrhoea or dehydration.
• Stop and seek medical care if there is severe cramping, persistent vomiting, faintness, blood in stool, confusion, very frequent watery stools, inability to drink fluids, or signs of dehydration.

Practical Takeaway

Danti is valuable precisely because it is strong. It is a classical purgative herb for Virechana and for selected Kapha-Pitta obstructive patterns, not a wellness trend. When selected by a trained Vaidya, prepared correctly, and monitored properly, it can serve a clear therapeutic purpose. When used casually, it can produce more harm than benefit.

The safest rule is simple: do not buy Danti and experiment with purgation on your own. If Virechana has been recommended for you, undergo it only under a qualified Ayurvedic physician who can assess your constitution, disease state, bowel tendency, strength, preparation needs, dose, and post-procedure care.

Safety disclaimer: This article is educational and does not diagnose, treat, or prescribe for any medical condition. Danti (Baliospermum montanum) is a potent purgative herb and should be used only under the direct supervision of a qualified Ayurvedic physician or appropriate healthcare provider. Do not use Danti during pregnancy, and do not use it for self-directed detox, constipation, weight loss, liver cleansing, or Panchakarma.

References

1. Ayurvedic Pharmacopoeia of India
2. Smpbkerala (smpbkerala.in)
3. Powo (powo.science.kew.org)
4. Powo (powo.science.kew.org)
5. Charaka Samhita — Dantidravanti Kalpa Adhyaya
6. Clinical study to evaluate the effect of Virechanakarma on serum electrolytes (2013), PubMed Central
7. Nia (nia.nic.in)
8. Analysis of Virechana karma with Danti avaleha: A retrospective study (2015), PubMed Central
9. Easyayurveda (easyayurveda.com)
10. Researchgate (researchgate.net)